Log book

Gene editing to prevent hereditary diseases

19 June 2017 | Alcim's articles

Alcimed, an innovation and new business consulting firm, highlights recent scientific developments in gene editing and discusses its future outlook. Gene editing accelerates due to CRISPR/Cas9 After several decades of slow development because of high cost, low efficiency, and poor accuracy of past techniques, the field of gene editing has undergone a dramatic expansion since […]

Read more

Gene-editing: What’s next after CRISPR Cas9?

22 February 2017 | Alcim's articles

Alcimed, an innovation and new business consulting firm, is committed to supporting the pharmaceutical industry in observing emerging technologies such as gene editing technologies CRISPR Cas9 and the following generations. Gene editing describes the process of insertion, deletion or replacing a specific gene of the genome of an organism to introduce a new function or […]

Read more